| Efficacy and safety of sirolimus in lymphangioleiomyomatosis FX McCormack, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ... New England Journal of Medicine 364 (17), 1595-1606, 2011 | 1155 | 2011 |
| Pulmonary alveolar proteinosis BC Trapnell, JA Whitsett, K Nakata New England Journal of Medicine 349 (26), 2527-2539, 2003 | 946 | 2003 |
| Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor T Kitamura, N Tanaka, J Watanabe, S Kanegasaki, Y Yamada, K Nakata The Journal of experimental medicine 190 (6), 875-880, 1999 | 601 | 1999 |
| Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan Y Inoue, BC Trapnell, R Tazawa, T Arai, T Takada, N Hizawa, Y Kasahara, ... American journal of respiratory and critical care medicine 177 (7), 752-762, 2008 | 532 | 2008 |
| Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and … H Masuki, T Okudera, T Watanebe, M Suzuki, K Nishiyama, H Okudera, ... International journal of implant dentistry 2, 1-6, 2016 | 447 | 2016 |
| Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis JF SEYMOUR, JJ Presneill, OD Schoch, GH Downie, PE Moore, IR Doyle, ... American Journal of Respiratory and Critical Care Medicine 163 (2), 524-531, 2001 | 316 | 2001 |
| Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. KOH Nakata, WN Rom, Y Honda, R Condos, S Kanegasaki, Y Cao, ... American journal of respiratory and critical care medicine 155 (3), 996-1003, 1997 | 310 | 1997 |
| Pulmonary alveolar proteinosis BC Trapnell, K Nakata, F Bonella, I Campo, M Griese, J Hamilton, T Wang, ... Nature Reviews Disease Primers 5 (1), 16, 2019 | 276 | 2019 |
| Serological diagnosis of idiopathic pulmonary alveolar proteinosis T Kitamura, K Uchida, N Tanaka, T Tsuchiya, J Watanabe, Y Yamada, ... American journal of respiratory and critical care medicine 162 (2), 658-662, 2000 | 266 | 2000 |
| Inhaled granulocyte/macrophage–colony stimulating factor as therapy for pulmonary alveolar proteinosis R Tazawa, BC Trapnell, Y Inoue, T Arai, T Takada, Y Nasuhara, N Hizawa, ... American journal of respiratory and critical care medicine 181 (12), 1345-1354, 2010 | 260 | 2010 |
| High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar … K Uchida, K Nakata, BC Trapnell, T Terakawa, E Hamano, A Mikami, ... Blood 103 (3), 1089-1098, 2004 | 252 | 2004 |
| Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. Y Zhang, K Nakata, M Weiden, WN Rom The Journal of clinical investigation 95 (5), 2324-2331, 1995 | 250 | 1995 |
| The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection JD Klausner, S Makonkawkeyoon, P Akarasewi, K Nakata, W Kasinrerk, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 11 (3), 247-257, 1996 | 211 | 1996 |
| Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International … LR Young, HS Lee, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ... The lancet Respiratory medicine 1 (6), 445-452, 2013 | 201 | 2013 |
| Granulocyte/macrophage–colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects K Uchida, K Nakata, T Suzuki, M Luisetti, M Watanabe, DE Koch, ... Blood, The Journal of the American Society of Hematology 113 (11), 2547-2556, 2009 | 171 | 2009 |
| Genetic variants of human β-defensin-1 and chronic obstructive pulmonary disease I Matsushita, K Hasegawa, K Nakata, K Yasuda, K Tokunaga, N Keicho Biochemical and biophysical research communications 291 (1), 17-22, 2002 | 169 | 2002 |
| Reciprocal CD4+ T-Cell Balance of Effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease … K Koyama, H Kagamu, S Miura, T Hiura, T Miyabayashi, R Itoh, ... Clinical cancer research 14 (21), 6770-6779, 2008 | 166 | 2008 |
| Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP) β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C … Y Honda, L Rogers, K Nakata, BY Zhao, R Pine, Y Nakai, K Kurosu, ... The Journal of experimental medicine 188 (7), 1255-1265, 1998 | 157 | 1998 |
| Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) K Isobe, T Watanebe, H Kawabata, Y Kitamura, T Okudera, H Okudera, ... International journal of implant dentistry 3, 1-6, 2017 | 145 | 2017 |
| Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines Y Hoshino, K Nakata, S Hoshino, Y Honda, DB Tse, T Shioda, WN Rom, ... The Journal of experimental medicine 195 (4), 495-505, 2002 | 144 | 2002 |
